CWIG
TSHA icon

Chung Wu Investment Group’s Taysha Gene Therapies TSHA Stock Holding History

Chung Wu Investment Group’s Portfolio TSHA Stock Details TSHA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.6K Hold
2,000
– – 0.01% 222
2026
Q1 		$8.94K Sell
2,000
-2,000
-50% -$9.3K 0.01% 214
2025
Q4 		$22K Buy
+4,000
New +$19.4K 0.02% 174

Other funds holding TSHA

ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Chung Wu Investment Group's TSHA Position: Q2 2026 in Review

Chung Wu Investment Group held its Taysha Gene Therapies (TSHA) position steady in Q2 2026 at 2,000 shares worth $13.6K. The position accounts for 0.01% of the portfolio, ranked #222.

Chung Wu Investment Group first reported a position in TSHA in Q4 2025 and has held it in 3 quarters since. The position peaked at $22K in Q4 2025. 209 funds tracked by Wall St. Rank hold TSHA as of Q2 2026.

  • Chung Wu Investment Group held 2,000 shares of Taysha Gene Therapies worth $13.6K as of Q2 2026.
  • Chung Wu Investment Group left its Taysha Gene Therapies share count unchanged in Q2 2026.
  • Taysha Gene Therapies made up 0.01% of Chung Wu Investment Group's portfolio in Q2 2026, its #222 holding.
  • Chung Wu Investment Group first reported a position in Taysha Gene Therapies in Q4 2025 and has held it in 3 quarters since.
  • Chung Wu Investment Group's Taysha Gene Therapies position peaked at $22K in Q4 2025.
  • 209 funds tracked by Wall St. Rank held Taysha Gene Therapies as of Q2 2026.

Based on Chung Wu Investment Group's 13F filing for Q2 2026, filed 31 Jul 2026.